Cargando…
Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) and antiphospholipid syndrome have an increased risk to develop cognitive impairment. A possible role for antiphospholipid antibodies (aPL) and antiglutamate receptor (anti-NMDA) antibodies in the pathogenesis of neurological manifestations of these two conditions,...
Autores principales: | Gerosa, Maria, Poletti, Barbara, Pregnolato, Francesca, Castellino, Gabriella, Lafronza, Annalisa, Silani, Vincenzo, Riboldi, Piersandro, Meroni, Pier Luigi, Merrill, Joan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740786/ https://www.ncbi.nlm.nih.gov/pubmed/26870034 http://dx.doi.org/10.3389/fimmu.2016.00005 |
Ejemplares similares
-
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019) -
IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Reshetnyak, Tatiana, et al.
Publicado: (2022) -
The Coexistence of Antiphospholipid Syndrome and Systemic Lupus Erythematosus in Colombians
por: Franco, Juan-Sebastian, et al.
Publicado: (2014) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021) -
Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome
por: Lonati, Paola Adele, et al.
Publicado: (2019)